Market News AIOpen the app

Zymeworks will spend $200 million to buy back its own shares.

PayoutRead the original at globenewswire.com
Good for ZYME

Zymeworks approved buying back up to $200 million of its stock and expects to use about $140 million through 2028, returning cash to shareholders. It completed its earlier program, authorized for up to $125 million, and says research and selective deals remain priorities.

ZYME · Zymeworks Inc.

AI read · Good for ZYME

The AI's read

Returning cash can support shareholders. Zymeworks also says research and selective deals remain priorities, so the repurchases will share cash with those plans. The company can change the pace based on cash flow and market conditions.

Get alerts for ZYME

Follow Zymeworks Inc. (ZYME) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ZYME
Free on the App Store and Google Play, or on the web.